Home › Compare › CCTL vs ABBV

CCTL vs ABBV: Dividend Comparison 2026

CCTL yields 2000000.00% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CCTL wins by $4.879226400974806e+39M in total portfolio value
10 years
CCTL
CCTL
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full CCTL calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — CCTL vs ABBV

📍 CCTL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCCTLABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CCTL + ABBV cover 4 of 12 months — good coverage

Jan
ABBV
Feb
—
Mar
—
Apr
ABBV
May
—
Jun
—
Jul
ABBV
Aug
—
Sep
—
Oct
ABBV
Nov
—
Dec
—
CCTL pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CCTL
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, CCTL beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CCTL + ABBV for your $10,000?

CCTL: 50%ABBV: 50%
100% ABBV50/50100% CCTL
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

CCTL
No analyst data
Altman Z
6.4
Piotroski
4/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+51.7% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CCTL buys
0
ABBV buys
0
No recent congressional trades found for CCTL or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCCTLABBV
Forward yield2000000.00% ✓3.67%
Annual dividend / share$2.00$6.20 ✓
Payout ratio50% ✓58%
1-year div growth0%4.7% ✓
5-year div CAGR0%8.9% ✓
Portfolio after 10y$4.879226400974806e+39M$39.9K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$1,154.43
Total dividends collected$4.879195005460081e+39M$7.2K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CCTL vs ABBV ($10,000, DRIP)

YearCCTL PortfolioCCTL Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,520$399.75+$200.00M → CCTL
2$3,738,731,768,458$3,738,517,757,009.35$13,261$450.98+$3738731.76M → CCTL
3$65,315,062,866,930,490$65,311,062,423,938,240.00$15,255$508.41+$65315062866.92M → CCTL
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$17,536$572.74+$1066400830062625.00M → CCTL
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$20,145$644.78+$16272182796453826560.00M → CCTL
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$23,126$725.38+$2.3205424011366188e+23M → CCTL
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$26,532$815.52+$3.0927990661046884e+27M → CCTL
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$30,420$916.26+$3.8524105697352695e+31M → CCTL
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$34,855$1,028.80+$4.484688260147987e+35M → CCTL
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$39,914$1,154.43+$4.879226400974806e+39M → CCTL

CCTL vs ABBV: Complete Analysis 2026

CCTL — Stock

Coin Citadel, a digital currency and blockchain investment company, focuses on building, operating, and supporting blockchain technologies. The company engages in cryptocurrency mining activities; and development of exchange and mining pool platforms. The company was formerly known as Global New Energy Industries Inc. and changed its name to Coin Citadel in November 2014. Coin Citadel was incorporated in 1986 and is based in Plattsburgh, New York.

Full CCTL Calculator →

ABBV — Healthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this CCTL vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CCTL vs SCHDCCTL vs JEPICCTL vs OCCTL vs KOCCTL vs MAINCCTL vs JNJCCTL vs MRKCCTL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.